Drug Establishment Registration and Drug Listing Requirements for Establishments Engaged in Distributed Manufacturing and Certain Foreign Establishments
🏛 Food and Drug Administration (FDA)FDA-2025-N-6075
Conformity Assessment & CertificationHealthcare Costs & AccessManufacturing & Supply ChainsPharmaceutical PolicySmall BusinessTobacco & Nicotine Products
Documents
18
Total comments
0
all analyzed
Comment status
Open
Last activity
—
In this docket
Documents
Rules, notices, and supporting material — the primary rule pinned first.
📄 Primary document
Proposed RuleJul 13, 2026
Drug Establishment Registration and Drug Listing Requirements for Establishments Engaged in Distributed Manufacturing and Certain Foreign
EstablishmentsOpen · 60 days left
- Supporting & Related Material· Jul 13, 2026
- Supporting & Related Material· Jul 13, 2026
- Supporting & Related Material· Jul 13, 2026
- Supporting & Related Material· Jul 13, 2026
- Supporting & Related Material· Jul 13, 2026
- Supporting & Related Material· Jul 13, 2026
- Supporting & Related Material· Jul 13, 2026
- Supporting & Related Material· Jul 13, 2026
- Supporting & Related Material· Jul 13, 2026
- Supporting & Related Material· Jul 13, 2026
- Supporting & Related Material· Jul 13, 2026
- Supporting & Related Material· Jul 13, 2026
- Supporting & Related Material· Jul 13, 2026
- Supporting & Related Material· Jul 13, 2026
- Supporting & Related Material· Jul 13, 2026
- Supporting & Related Material· Jul 13, 2026
- Supporting & Related Material· Jul 13, 2026
